Alligator Bioscience
0,031
SEK
-6,12 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-6,12%
+45,24%
+45,82%
-50,53%
-72,53%
-71,59%
-76,78%
-92,32%
-98,21%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Læs mereMarkedsværdi
886,3 mio. SEK
Aktieomsætning
1,12 mio. SEK
Omsætning
57,77 mio.
EBIT %
-396,64 %
P/E
-
Udbytteafkast, %
-
Finanskalender
24.4
2025
Delårsrapport Q1'25
5.7
2025
Generalforsamling '25
10.7
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Alligator Bioscience: BioStock: Alligator's CEO: "I'm confident that we will strike a deal"
Alligator Bioscience Announces Publication of Clinical Data for ATOR-1017 (evunzekibart) in the Journal for ImmunoTherapy of Cancer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools